Arterial hypertension in the post-Covid period: literature review
Year: 2025
Type: article
Abstract: During the pandemic of the new coronavirus infection, the most common comorbid pathology in patients with laboratory confirmed cases of COVID-19 was arterial hypertension (AH) due to the participation of the renin-angiotensin-aldosterone system components in the penetration of the SARS-CoV-2 virus into the human body and the similarity of the pathogenesis of these diseases. One of the manifestations of post-Covid syndrome in АН is destabilization of blood pressure, insufficiency of antihypertensive therapy effectively conducted before, uncontrolled hypertension, requiring intensified therapy, the development of resistant hypertension in some cases, high incidence of target organs damage. The frequency of new cases of hypertension 3 and 4–6 months after COVID-19 was low.
Source: Perm Medical Journal
DOI: 10.17816/pmj4215-11
Authors: E. V. Zolotukhina, L. A. Panacheva
Institution: Novosibirsk State Medical University
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4408412442